In the current study, we aimed at identifying the functional role of transient receptor potential vanilloid-3 (TRPV3) ion channel in the regulation of human hair growth.
as "polymodal cellular temperature sensor" molecules. Indeed, these channels were shown to be involved in sensation of e.g. temperature challenges, chemical irritants, osmolarity, taste, pain, itch, etc. (Clapham, 2003; Nilius et al., 2007; Szállási and Blumberg, 1999; Caterina and Julius, 2001; Paus et al., 2006a; Bíró et al., 2007) .
Emerging results of the past decade, however, have suggested that roles of TRP channels are, by no means, restricted to sensory neuron-coupled processes.
Stimulated not the least by our pioneering studies with TRPV1 (the "capsaicin receptor" of the vanilloid subgroup) on glial and mast cells (Bíró et al., 1998a (Bíró et al., , 1998b , it has now become clear that functional TRP channels are also expressed on many different non-neuronal cell types. In the skin, TRPV1 was identified on human epidermal and hair follicle keratinocytes, sebocytes, mast cells, and dendritic cells (Denda et al., 2001; Southall et al., 2003; Bodó et al., 2004) . We have also shown that TRPV1 activation suppressed in vitro human hair growth, inhibited proliferation of epidermal keratinocytes and sebocytes, induced apoptosis of skin cells, and inhibited lipid synthesis of sebocytes (Bodó et al., 2005; Tóth et al., 2009b) . Finally, we have detected a significant delay in hair follicle cycling of TRPV1 KO mice compared to the wild-type control (Bíró et al., 2006) . These findings have introduced TRPV1 as a significant novel player in human (and murine) skin and hair growth control, and suggested that TRP channels and their endogenous ligands may represent additional players in the neuroendocrine network of the skin (Slominski and Wortsman, 2000) . Intriguingly, another thermosensitive TRP channel, i.e. TRPV3, which is abundantly expressed in murine keratinocytes (Xu et al., 2002; Smith et al., 2002; Peier et al., 2002; Moussaieff et al., 2008) , was recently also implicated in the regulation of murine epidermal and hair growth. It was also shown that a constitutively active, "gain-of-function" mutation of the trpv3 gene resulted in a hairless phenotype in mice (and rats) (Asakawa et al., 2006; Xiao et al., 2008) . Finally, an elegant study (Cheng et al., 2010) has recently demonstrated that TRPV3-coupled signaling mechanisms are key regulators of epidermal growth factor-induced murine hair morphogenesis and skin barrier formation.
Although these interesting data strongly suggested that TRPV3 (similar to TRPV1) may play a profound regulatory role in murine hair growth (Steinhoff and Bíró, 2009 ); moreover, although expression of TRPV3 was identified in the human skin in situ (Xu et al., 2002; Gopinath et al., 2005; Facer et al., 2007) , we lack data on its function in human hair growth control. Therefore, in the current study, we aim at defining whether TRPV3-coupled signaling is involved in the regulation of human hair growth and cycling. Specifically, we intended to identify the expression of TRPV3 in human organ-cultured hair follicles (HF) and in primary cultures of HF-derived outer root sheath (ORS) keratinocytes using immunolabeling and quantitative "real-time" PCR.
Furthermore, using a wide-array of functional assays and molecular imaging, we have evaluated the effects of plant-derived and synthetic TRPV3 activators on hair shaft elongation, intrafollicular and ORS keratinocyte proliferation and apoptosis, HF cycling, intracellular ionic homeostasis, and channel activity. Finally, we have analyzed the TRPV3-specificity of the observed cellular actions of the TRPV3 agonists using RNA-interference. Collectively, our study provides the first evidence that activation of TRPV3 inhibits human hair growth which findings strongly argue for that TRPV3 and the related intracellular signaling mechanism might function as a promising, novel target for pharmacological manipulations of clinically relevant hair growth disorders. 
RESULTS

Human scalp HF express TRPV3 mainly in the ORS
First, we intended to define TRPV3 expression in the human HF in vivo, using fullthickness normal scalp skin obtained during routine plastic surgery. As revealed by immunohistochemistry, TRPV3-immunoreactivity (ir) in human scalp HF in anagen VI stage of the hair cycle (Paus and Cotsarelis, 1999; Stenn and Paus, 2001 ) was restricted mostly to the keratinocyte layers of the ORS and, to lesser extent, to the matrix of the HF (Figure 1a) . In good accord with these data, a strong TRPV3-ir was observed on cultured ORS keratinocytes, both by immunocytochemistry (Figure 1b) and Western blotting (Figure 1c) . The specificity of the immunosignal was assessed by numerous positive and negative controls (see also Materials and methods section for details).
In order to control whether intraepithelial TRPV3-ir corresponded to the presence of TRPV3 transcripts, RNA was rapidly extracted from freshly microdissected proximal human anagen HFs and from ORS keratinocyte cultures and then samples were subjected to Q-PCR. As shown in Figure 1d , mRNA transcripts for TRPV3 were unambiguously identified both in normal human scalp HF and in HF-derived ORS keratinocytes suggesting that the human HF epithelium indeed transcribes the TRPV3 gene in vivo.
In these experiments, two other important findings have been revealed. First, TRPV3-ir ( Figure 1a ) and specific mRNA transcripts (Figure 1d) were absent from the inductive, specialized HF mesenchyme, the fibroblasts of the dermal papilla (DP) as well as from human dermal fibroblast (HDF) (Figure 1d ) used as feeder layers for the ORS keratinocyte cultures. Second, expression of TRPV3 in the ORS and matrix keratinocyte layers of the human HF appeared to be not regulated by the cycling machinery of the HF since the levels of TRPV3-specific mRNA transcripts ( Figure   1d ) and ir (data not show) were essentially the same in anagen and in spontaneously transformed catagen HFs.
TRPV3 stimulation inhibits hair shaft elongation and hair matrix keratinocyte proliferation, and induces apoptosis-driven premature catagen regression
In order to explore the functional consequences of TRPV3 stimulation in vitro under as physiological conditions as possible, microdissected, organ-cultured normal anagen VI scalp HF were exposed to various TRPV3 agonists (Xu et al., 2006; Chung et al., 2004a) . Plant-derived agents such as eugenol (Figure 2) , thymol, and carvacrol (data not shown) -major components of clove, thyme, and oregano -and well as the synthetic agonist 2-APB significantly inhibited hair shaft elongation in a time-and dose-dependent manner (Figure 2a) .
Hair growth inhibition was further confirmed by the finding that treatment of cultured HFs by these activators for 5 days significantly decreased the number of Ki67+ keratinocytes in the anagen hair bulb (Figure 2b) . Of further importance, the above agents significantly increased the number of TUNEL+ keratinocytes in the hair bulb after stimulation, suggesting the induction of apoptosis by TRPV3 stimulation (Figure   2b ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  R  e  v  i  e  w  O  n  l  y   8 Using quantitative histomorphometry of HE-staining section of HF and analyzing such staining based on well-defined morphological criteria (Stenn and Paus, 2001; Müller-Röver et al., 2001) , we next assessed the effect of the TRPV3 agonists on HF cycling in vitro, namely on the anagen-catagen transition, which is characterized by massive up-regulation of keratinocyte apoptosis and down-regulation of keratinocyte proliferation in the anagen hair bulb (Stenn and Paus, 2001; Müller-Röver et al., 2001; Lindner et al., 1997) . As shown in Figure 2c , the agonists stimulated the onset of catagen transformation of the HF; whereas in the control, most of the HF (>80 %) were in the anagen VI phase, after 8 days of treatment with eugenol or 2-APB, 60-100% of the HF had entered catagen (Figure 2c ). It should be noted, however, that these TRPV3 agonists were largely capable of inducing only early catagen stages, and that we very rarely found that HF regression in vitro had progressed into late stages of the catagen transformation after application of these agents.
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TRPV3 is expressed as a Ca
2+ -permeable ion channel on ORS keratinocytes
Although the above data argued for the functional expression of TRPV3 in keratinocyte layers of the human HF, to further analyze the functionality of the TRPV3 channel, a series dynamic imaging and electrophysiology experiments were performed on primary cultures of human ORS keratinocytes which, as we have shown above (Figure 1) , express TRPV3-specific mRNA transcripts and proteins.
As revealed by FLIPR-based Ca 2+ -imaging (Tóth et al., 2009b; Marincsák et al., 2008) (Figure 3a and b) . Of further importance, suppression of [Ca 2+ ] of the culturing medium (from 1.8 mM to 0.02 mM) or co-application of 10 µM ruthenium red (a nonselective channel blocker) (Amann and Maggi, 1991) almost fully prevented the actions of the TRPV3 agonists to elevate [Ca 2+ ] ic (Figure 3b ) suggesting that these agents opened a Ca
2+
-permeable conductance at the surface membrane of the ORS keratinocytes.
To further assess this phenomenon, patch-clamp (whole cell configuration) experiments were performed. Since membrane currents elicited by square pulses activated quickly and showed no time and voltage dependent inactivation (data not shown), currents were initiated by ramp protocols (Figure 3c ), applied in every 3 sec.
Control (i.e. vehicle-treated) ORS keratinocytes showed outwardly rectifying currents with an average reversal potential of -12.6±1.5 mV (mean±SEM, n=7). Currents were measured and normalized to cell membrane capacitance at four different potential during the ramp protocol, i.e. at -90, -40, +40 and +90 mV resulting -9.5±2.5, -3.5±1.0, 6.2±1.0, and 15.9±3.5 pA/pF, respectively (all data are mean±SEM values) (Figure 3e ).
Of great importance, both inward and outward currents were markedly and significantly (p<0.05) increased by 100 µM 2-APB (Figure 3c-f) which effect was reversible. In the presence of 2-APB, the currents measured at -90, -40, +40 and +90 mV were -31.9±14.2, -13.8±6.4, 17.3±6.1, and 57.7±16.6 pA/pF, respectively (mean±SEM, n=7). In average, the TRPV3 activator approximately tripled both inward and outward currents at all potentials. (Notably, all other plant-derived TRPV3 activator exerted similar effects; data not shown). We have also shown that 10 µM Collectively, these data unambiguously argue for that human HF-derived ORS keratinocytes indeed express functional TRPV3 which operates as a Ca 2+ -permeable (most probably non-selective cation) channel at the plasma membrane of the cells, similar to as had previously been described on various epidermal keratinocyte populations (Peier et al., 2002; Cheng et al., 2010; Chung et al., 2004a Chung et al., , 2004b Huang et al., 2008) .
TRPV3 stimulation suppresses proliferation of ORS keratinocytes and induces cell death
Since TRPV3 stimulation of organ-cultured HFs inhibited hair shaft elongation and intrafollicular proliferation and induced apoptosis (Figure 2) , we next investigated the cellular effects of TRPV3 activation on growth and survival of human ORS keratinocytes. In good accord with these data, as revealed by a wide-array of FLIPRbased functional assays, eugenol and 2-APB suppressed cellular growth of ORS keratinocytes in a dose-dependent manner (Figure 4a-c) . In addition, the TRPV3 activators markedly suppressed the mitochondrial membrane potential (Figure 4a-c) , one of the earliest hallmarks of apoptosis (Green and Reed, 1998; Susin et al., 1998) . Finally, highest concentrations of the agents were also able to significantly (p<0.05) increase Sytox Green accumulation (Figure 4a) , a sensitive indicator of necrosis/cytotoxicity (Tóth et al., 2009b; Dobrosi et al., 2008) . However, several lines of evidence suggest that the above agents may also activate other TRP channels (Bíró et al., 2007; Xu et al., 2006) . Furthermore, we lack highly selective and commercially available TRPV3 inhibitors. Therefore, in order to further assess and verify the TRPV3-specificity of the above cellular responses, a series of TRPV3-targeted RNAi knock-down experiments were carried out in accordance with the techniques developed in our previous studies and which were optimized for 
DISCUSSION
Uncovering the as yet ill-characterized functions of various TRP channels in human skin biology and pathology is an important, integral part of the ongoing exploration of the emerging roles of these molecules in regulatory mechanisms of non-neuronal tissues and cells (Clapham, 2003; Nilius et al., 2007; Szállási and Blumberg, 1999; Caterina and Julius, 2001; Paus et al., 2006a; Bíró et al., 2007) . In this context, we provide the first evidence that TRPV3, by suppressing HF keratinocyte proliferation and inducing apoptosis-driven catagen regression, inhibits in vitro human hair growth.
Given that these effects were generated with intact components of a normal human mini-organ and under assay conditions that preserve in vivo-like key functions of this organ during the test period, our findings are both physiologically and clinically relevant. Therefore, our current results, which are perfectly in line with previous data obtained on various mouse models (Asakawa et al., 2006; Xiao et al., 2008; Cheng et al., 2010; Steinhoff and Bíró, 2009; Imura et al., 2007) , introduces TRPV3 as a significant novel player in human hair growth and cycling control. were also inhibited by these manipulations and, of greatest importance, by the RNAi ] ic elevations were identified in these cells (Peier et al., 2002; Xiao et al., 2008; Cheng et al., 2010 , Chung et al., 2004a , 2004b Huang et al., 2008) . In addition, stimulation of TRPV3 on keratinocytes induced the release of various mediators (e.g. interleukin 1α, prostaglandin E2, ATP) (Xu et al., 2006; Huang et al., 2008; Mandadi et al., 2009 ) which, as "intercellular messengers", were shown to activate pain and/or itch sensitive sensory afferents (Huang et al., 2008; Mandadi et al., 2009 ). However, these mediators are recognized proinflammatory agents in the skin (Bíró et al., 1998b (Bíró et al., , 2007 Paus and Cotsarelis, 1999; Stenn and Paus, 2001; Paus et al., 2006b ); hence, TRPV3 channels expressed on keratinocytes were suggested to play a role in cutaneous inflammation.
Indeed, transgenic overexpression of a "gain-of-function" mutant of the trpv3 gene in epidermal keratinocytes of mice resulted in not only pruritus but severe dermatitis as well (Yoshioka et al., 2009) . Furthermore, our preliminary data suggest that activation of TRPV3 significantly suppresses growth of human epidermal keratinocytes (Bíró et al., manuscript in preparation) . These intriguing findings, along with our current presentation on the role of TRPV3 in human (and mouse) hair growth control, underscore the key physiological and pathophysiological significance of TRPV3, its 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Of further importance, we and others have identified almost identical cutaneous regulatory mechanisms with the central involvement of another TRP channel, i.e.
TRPV1. Indeed, stimulation of TRPV1 was shown to inhibit human (and murine) hair growth, promote premature catagen regression of the human HF, suppress proliferation and induce apoptosis of human epidermal and ORS keratinocytes, and induce the release of pro-inflammatory cytokines from these cells (Southall et al., 2003; Bodó et al., 2005; Bíró et al., 2006 ). It appears, therefore, that TRPV3-coupled signaling mechanisms (similar to those initiated by the activation of cutaneous TRPV1) act as key regulators of human hair growth and cycling and, most probably, other key biological processes of the skin.
In various heterologous systems ectopically expressing certain TRPs, the TRPV3 activator 2-APB was shown to be able to activate TRPV1 (Hu et al., 2004 ) (and possibly other TRP channels as well). However, according to our best knowledge, there is no data available on the effect of 2-APB on endogenous TRPV1 expressed by cultured human or mouse keratinocytes. Since (1) various agents may exert completely different affinities to "naïve" and "expressed" channels; and (2) we have previously shown that the activation of TRPV1 by capsaicin on human ORS keratinocytes induced TRPV1-specific influx of Ca 2+ (Bodó et al., 2005) , arguing for the functional expression of TRPV1 channels in the surface membrane of the ORS keratinocytes; our results that TRPV3 siRNA treatment completely abolished the effects of 2-APB suggest that the effects of 2-APB to increase [Ca 2+ ] ic and induce 
MATERIALS AND METHODS
Materials
Eugenol, carvacrol, thymol, and 2-aminoethoxydiphenyl borate (2-APB) were purchased from Sigma-Aldrich (St. Louis, MO).
Isolation and maintenance of HFs
The study was approved by the Institutional Research Ethics Committees and adhered to Declaration of Helsinki guidelines. Human anagen VI HFs (n=18-24 per group) were isolated from skin obtained from males undergoing hair transplantation or females undergoing face-lift surgery as we have described before (Bodó et al., 2005 (Bodó et al., , 2009 Telek et al., 2007; Ramot et al., 2010) . Isolated HFs were maintained in Williams' E medium (Invitrogen, Paisley, UK) supplemented with 2 mM L-glutamine (Invitrogen), 10 ng/ml hydrocortisone, 10 µg/ml insulin, and antibiotics (all from Sigma-Aldrich). Medium was changed every other day whereas treatment with various TRPV3 activators was performed daily. Length measurements were performed on individual HFs using a light microscope with an eyepiece measuring graticule.
Histology
Cryostat sections (6 µm) of cultured HFs were fixed in acetone, air-dried, and processed for histology. Hematoxylin and eosin (HE, Sigma-Aldrich) staining was was assessed according to defined morphological criteria (Bodó et al., 2005 (Bodó et al., , 2009 Telek et al., 2007; Ramot et al., 2010) .
ORS keratinocyte cultures
Anagen HFs were digested using trypsin to obtain ORS keratinocytes (Bodó et al., 2005; Ramot et al., 2010; Limat and Noser, 1986) . Similarly, human dermal fibroblasts (HDFs) were obtained from de-epidermized dermis using enzymatic digestion. ORS cultures were kept on feeder layer of mitomycin-treated HDFs (Bodó et al., 2005; Limat et al., 1989 ) in a 1:3 mixture of Ham's F12 and Dulbecco's modified Eagle's medium (both from Invitrogen) supplemented with 0.1 nM cholera toxin, 5 µg/ml insulin, 0.4 µg/ml hydrocortisone, 2.43 µg/ml adenine, 2 nM triiodothyronine, 10 ng/ml epidermal growth factor, 1 mM ascorbyl-2-phosphate, and antibiotics (all from Sigma-Aldrich).
Immunolabeling of TRPV3
For the detection of TRPV3 on isolated HFs and ORS keratinocytes, we performed fluorescent immunolabeling (Bodó et al., 2005 (Bodó et al., , 2009 Telek et al., 2007; Ramot et al., 2010; Poeggeler et al., 2010 an Eclipse E600 fluorescent microscope (Nikon, Tokyo, Japan). As negative controls, the appropriate primary antibodies were either omitted from the procedure or were preabsorbed with synthetic blocking peptides. In addition, the specificity of TRPV3 staining was also measured on tissues recognized to be positive for the channel; i.e. 
Ki-67/TUNEL double labeling
To evaluate apoptotic cells in the HFs in co-localization with a proliferation marker Ki-67, a Ki-67/TUNEL (terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling) double-staining method was employed (Bodó et al., 2005 (Bodó et al., , 2009 Telek et al., 2007) . Cryostat sections were fixed in formalin/ethanol/acetic acid and labeled with a digoxigenin-deoxyUTP (ApopTag Fluorescein In Situ Apoptosis detection kit; Millipore, Billerica, MA) in presence of terminal deoxynucleotidyl transferase (TdT), followed by incubation with a mouse anti-Ki-67 antiserum (DAKO, Carpinteria, CA). 
Quantitative "real-time" PCR (Q-PCR)
Q-PCR was performed on an ABI Prism 7000 sequence detection system (Applied Biosystems, Foster City, CA) by using the 5' nuclease assay as we have previously described (Bodó et al., 2005 (Bodó et al., , 2009 Telek et al., 2007; Ramot et al., 2010; Poeggeler et al., 2010) . Total RNA was isolated using TRIzol reagent (Invitrogen) according to manufacturer's protocol. Three µg of total RNA were then reverse-transcribed into cDNA by using 15 U of AMV reverse transcriptase (Promega, Madison, WI) and 0.025 µg/µl random primers (Promega). PCR amplification was performed by using the TaqMan primers and probes (TRPV3, assay ID, Hs00376854_m1) using the TaqMan universal PCR master mix protocol (Applied Biosystem). As internal controls, transcripts of glycerinaldehyde 3-phosphate dehydrogenase (GAPDH, assay ID Hs99999905_m1) and cyclophylin (PPIA, assay ID Hs99999904_m1) were determined.
Western blotting
To determine the expression of TRPV3 in different keratinocyte cell types, the Western blot technique was applied (Bíró et al., 1998a (Bíró et al., , 1998b Bodó et al., 2004 Bodó et al., , 2005 Telek et al., 2007) . Cell lysates of ORS and HaCaT keratinocytes (the latter cells were used as positive controls) (Sherkheli et al., 2009 ) were subjected to SDS-PAGE, transferred to BioBond nitrocellulose membranes (Whatman, Maidstone, UK), ] i (reflected by changes in fluorescence; λ EX =494 nm, λ EM =516 nm) induced by various concentrations of the drugs were recorded in each well (during the measurement, cells in a given well were exposed to only one given concentration of the agent). Experiments were performed in quadruplets and the averaged data (±SEM) were used in the calculations (Marincsák et al., 2008; Tóth et al., 2009a) . resistance seal by gentle suction, the cell membrane beneath the tip of the electrode was disrupted by further suction and/or by applying 1.5 V electrical pulses for 1 ms.
Ion currents were normalized to cell capacitance, determined in each cell using short hyperpolarizing pulses from -10 mV to -20 mV. Average cell capacitance was 34.5±2.5 pF whereas the series resistance was typically 5-10 MΩ and left uncompensated. Experiments were discarded when the amplitude of the measured current was unstable within the initial 5 min of the experiment, or the series resistance was high or increased during the measurement. Outputs from the clamp amplifier were digitized at 10 kHz using an A/D converter (Digidata-1322A, Axon 
Determination of cellular proliferation
The degree of cellular growth (reflecting number of viable cells) was determined by measuring the DNA content of cells using CyQUANT Cell Proliferation Assay Kit (Invitrogen). ORS keratinocytes (10000 cells/well) were cultured on mitomycin treated HDF feeder cells (900 cells/well) in 96-well black-well/clear-bottom plates (Greiner Bio One) in quadruplicates and were treated with various compounds for the time indicated. Supernatants were then removed by blotting on paper towels, and the plates were subsequently frozen at -70°C. The plates were then thawed at room temperature, and 200 µl of CyQUANT dye/cell lysis buffer mixture was added to each well. After 5 min incubation, fluorescence was measured at 490 nm excitation and 520 nm emission wavelengths using FLIPR (Molecular Devices) (Tóth et al., 2009b) .
Determination of apoptosis
A decrease in the mitochondrial membrane potential is one of the earliest markers of apoptosis (Green and Reed, 1998; Susin et al., 1998) . Mitochondrial membrane potential of ORS keratinocytes was determined using a MitoProbe DiIC 1 (5) Assay Kit (Invitrogen) using our previously optimized protocols (Tóth et al., 2009b; Dobrosi et al., 2008) . Cells were cultured and treated as described above. After removal of supernatants, cells were incubated for 30 minutes with DilC 1 (5) working solution and 
Determination of necrosis
Necrotic cell death was determined by SYTOX Green nucleic acid staining (Invitrogen). The dye is able to penetrate only to necrotic cells with ruptured plasma membranes, whereas healthy cells with intact surface membranes show negligible staining. Cells were cultured and treated as described above. Supernatants were then discarded and the cells were incubated with 1 µM SYTOX Green solution.
Fluorescence of SYTOX Green was measured at 490 nm excitation and 520 nm emission wavelengths using a FLIPR (Tóth et al., 2009b; Dobrosi et al., 2008) .
RNA interference (RNAi)
ORS keratinocytes were transfected by the Neon Transfection System (Invitrogen) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 , 2009b; Dobrosi et al., 2008; Griger et al., 2007) . In all cases, the specific RNAi probes resulted in >70% suppression of the expression of TRPV3 by day 2 and remained suppressed for 2 additional days (data not shown). Hence, experiments were performed 2 days after transfection.
Statistical analysis
When applicable, data were analyzed using a two-tailed unpaired t-test (except for analyzing the patch-clamp data where Student's t-test for paired data was applied) and p<0.05 values were regarded as significant differences.
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